Skip to main content
. 2017 Oct 9;11(10):e0006001. doi: 10.1371/journal.pntd.0006001

Fig 4.

Fig 4

Median percentage of IL-17 producing cells: (A) in patients with ENL and LL controls before, during and after treatment, (B) within ENL patients before, during and after treatment. * P≤0.05; ** P≤ 0.0.005; *** P< 0.001; **** P< 0.0001. Box and whiskers (A) and Error bars (B) show median ± interquartile range.